Skip to content

Dexamethasone for Reduction of Post Thoracotomy Pain Syndrome

Chronic Pain | Thoracic Surgery | Cytokines | Dexamethasone

Post thoracotomy pain syndrome still affects 50% of patients after a thoracic surgery. Pathogenesis is unclear but there is growing evidence that neuro inflammation may play a significant role. Dexamethasone is a very potent anti-inflammatory drug. The hypothesis of this study is that dexamethasone, given pre operatively, would help reduce the incidence of post thoracotomy pain syndrome 3 months after surgery, by reducing the inflammatory response, in patients undergoing elective thoracic surgery that includes thoracic epidural analgesia.

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    18 to 75

Critères de participation

Inclusion Criteria:

* elective thoracic surgery using a thoracotomy incision and thoracic epidural analgesia
* ASA I-III
* age 18-75 yo

Exclusion Criteria:

* contra-indication to thoracic epidural analgesia
* patient refusal
* patients already taking cortisone or dexamethasone
* patients on chronic opioid medication

Lieu de l'étude

Maisonneuve-Rosemont Hospital
Maisonneuve-Rosemont Hospital
Montreal, Quebec
Canada

Contactez l'équipe d'étude

Primary Contact

Brulotte Veronique, MD, MSc

[email protected]
514 252-3400
Étude parrainée par
Maisonneuve-Rosemont Hospital
Participants recherchés
Plus d'informations
ID de l'étude: NCT02112864